News Releases

Date Title and Summary
Toggle Summary electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC.
ROCKAWAY, NJ , Aug. 24, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced a reseller agreement with Red One Medical Devices, LLC . (Red One). The partnership will further expand availability of electroCore’s gammaCore
Toggle Summary Study of Non-Invasive Vagus Nerve Stimulation (nVNS) Shows Improvement in PTSD Symptoms and Decreased Inflammatory Response to Stress
ROCKAWAY, NJ , Aug. 10, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc.  (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer reviewed manuscript, “Transcutaneous Cervical Vagal Nerve Stimulation (tcVNS/nVNS) in Patients with Posttraumatic Stress
Toggle Summary electroCore Announces Second Quarter 2021 Financial Results
Second quarter 2021 net sales of $1.3 million, increased 69% over second quarter 2020 and 5% sequentially. Company to host a conference call and webcast today, August 5, 2021 at 4:30 pm ET ROCKAWAY, NJ , Aug. 05, 2021 (GLOBE NEWSWIRE) --   electroCore, Inc.
Toggle Summary electroCore Announces Publication in PharmacoEconomics Reiterating Economic Benefits of gammaCore for Cluster Headache Outlined by The National Institute for Health and Care Excellence (NICE) Medical Technologies Guidance
ROCKAWAY, NJ , Aug. 04, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company (the Company), today announced the release of an article entitled “gammaCore for Cluster Headaches: A NICE Medical Technologies Guidance” in the journal
Toggle Summary electroCore to Present at the Canaccord Genuity Growth Conference
ROCKAWAY, NJ , Aug. 02, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation and be available for virtual one-on-one meetings at the Canaccord
Toggle Summary electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones
ROCKAWAY, NJ , July 27, 2021 (GLOBE NEWSWIRE) --   electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,065,444 to electroCore, relating to the use of a mobile
Toggle Summary electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th
ROCKAWAY, NJ , July 22, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second quarter ended June 30, 2021 after the close of the market on Thursday, August 5, 2021 .
Toggle Summary electroCore announces Dr. Peter Staats to receive Lifetime Achievement Award from the American Society of Pain and Neuroscience
ROCKAWAY, NJ , July 19, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its cofounder and Chief Medical Officer, Dr. Peter Staats , is to receive a Lifetime Achievement Award at the American Society
Toggle Summary electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance
Second-Quarter 2021 revenue expected to be approximately   $ 1.3 million Net cash used to fund operations in   the second quarter 2021 of approximately $ 3.2 million Follow on offering subsequent to June 30, 2021   added $18 . 8 million to cash balance ROCKAWAY, NJ , July 13, 2021 (GLOBE NEWSWIRE)
Toggle Summary electroCore to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference
ROCKAWAY, NJ , July 09, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger , CEO will present a company overview and be available for 1x1 meetings at the following upcoming conference: Ladenburg Thalmann